Not finding it? Sign in to also search OpenAlex live.
-
OX40 agonism enhances efficacy of PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access
Guillaume Beyrend, Tetje Cornelia van der Sluis, Esmé T.I. van der Gracht, Tamim Abdelaal, Simon P. Jochems, Robert A. Belderbos, +16 more
0citations -
59 Bispecific antibody ubamatamab elicits patient-specific anti-tumor and immune responses in an ex vivo ovarian cancer platform2025 Journal for ImmunoTherapy of Cancer conference-abstract Medicine Ovarian cancer diagnosis and treatment Open access
Felix M. Behr, Esmee Koedoot, Timothy J. P. Sijsenaar, Léa Le Large, Cor Doede de Kroon, Anne M. van Altena, +6 more
0citations -
Late Breaking Abstract - Discovery of an MMP7‑driven CTGF proteolytic switch as a new therapeutic intervention in IPF2026 European Respiratory Journal conference-abstract Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Maria Myzithras, Fidel Ramírez, Ryan M. Sheehan, Priyanka Gupta, Julia Sauer, Heiko F. Stahl, +32 more
0citations -
721 AT1412, a patient-derived CD9 antibody in preclinical development promoting tumor immune infiltration and inducing tumor rejection2020 Regular and Young Investigator Award Abstracts conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Remko Schotte, Julien Villaudy, Martijn Kedde, Wouter Pos, Daniel Go, Christien Fatmawati, +10 more
0citations -
Intratumoral gene delivery of 4-1BBL boosts IL-12-triggered anti-glioblastoma immunity2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Glioma Diagnosis and Treatment Open access
Taral R. Lunavat, Lisa Nieland, Sanne M. van de Looij, Alexandra J E M de Reus, Charles Couturier, Chadi A. El Farran, +18 more
0citations